BRPI0812026A2 - mutantes de vegf-d e seu uso - Google Patents

mutantes de vegf-d e seu uso

Info

Publication number
BRPI0812026A2
BRPI0812026A2 BRPI0812026A BRPI0812026A BRPI0812026A2 BR PI0812026 A2 BRPI0812026 A2 BR PI0812026A2 BR PI0812026 A BRPI0812026 A BR PI0812026A BR PI0812026 A BRPI0812026 A BR PI0812026A BR PI0812026 A2 BRPI0812026 A2 BR PI0812026A2
Authority
BR
Brazil
Prior art keywords
vegf
mutants
angiogenesis
promotion
therapy
Prior art date
Application number
BRPI0812026A
Other languages
English (en)
Inventor
Kari Juhani Airenne
Pyry Toivanen
Seppo Ylä-Herttuala
Original Assignee
Ark Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Ltd filed Critical Ark Therapeutics Ltd
Publication of BRPI0812026A2 publication Critical patent/BRPI0812026A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0812026A 2007-05-31 2008-06-02 mutantes de vegf-d e seu uso BRPI0812026A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0710457.3A GB0710457D0 (en) 2007-05-31 2007-05-31 Vegf Mutants
PCT/GB2008/001873 WO2008146023A1 (en) 2007-05-31 2008-06-02 Vegf-d mutants and their use

Publications (1)

Publication Number Publication Date
BRPI0812026A2 true BRPI0812026A2 (pt) 2015-09-29

Family

ID=38289657

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812026A BRPI0812026A2 (pt) 2007-05-31 2008-06-02 mutantes de vegf-d e seu uso

Country Status (13)

Country Link
US (1) US8188039B2 (pt)
EP (1) EP2162463B1 (pt)
JP (1) JP2010527627A (pt)
KR (1) KR101522043B1 (pt)
CN (1) CN101730710A (pt)
AT (1) ATE550351T1 (pt)
AU (1) AU2008256550B2 (pt)
BR (1) BRPI0812026A2 (pt)
CA (1) CA2688543C (pt)
EA (1) EA200971092A1 (pt)
GB (1) GB0710457D0 (pt)
MX (1) MX2009012599A (pt)
WO (1) WO2008146023A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2393832B1 (en) * 2009-02-06 2015-07-08 Pepscan Systems BV Truncated cystine-knot proteins
CN102336811B (zh) * 2010-07-26 2016-03-16 上海市第一人民医院 一类新的抑制新生血管的小肽及其应用
WO2012088563A1 (en) * 2010-11-24 2012-07-05 Vegenics Pty Limited Vegfr-2-specific forms of vegf-d and vegf-c and uses thereof

Also Published As

Publication number Publication date
MX2009012599A (es) 2009-12-11
AU2008256550B2 (en) 2012-02-09
KR101522043B1 (ko) 2015-05-20
ATE550351T1 (de) 2012-04-15
US8188039B2 (en) 2012-05-29
JP2010527627A (ja) 2010-08-19
US20110144013A1 (en) 2011-06-16
CA2688543A1 (en) 2008-12-04
CN101730710A (zh) 2010-06-09
GB0710457D0 (en) 2007-07-11
KR20100040805A (ko) 2010-04-21
WO2008146023A1 (en) 2008-12-04
CA2688543C (en) 2017-08-22
EP2162463B1 (en) 2012-03-21
EP2162463A1 (en) 2010-03-17
AU2008256550A1 (en) 2008-12-04
EA200971092A1 (ru) 2010-06-30

Similar Documents

Publication Publication Date Title
CY1120407T1 (el) Φαρμακοτεχνικες μορφες ινσουλινων μακρας-δρασεως
EA201001628A1 (ru) Модифицированные полипептиды фактора vii и их применение
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
CY1118038T1 (el) Λυοφιλισμενες φαρμακοτεχνικες μορφες θεραπευτικου πεπτισωματος
UA94221C2 (en) Lipocalin protein
MX349513B (es) Materiales y metodos para el tratamiento o prevencion de enfermedades asociadas al her-3.
AR082017A1 (es) Anticuerpos anti-axl (receptor de tirosina quinasas) y metodos de uso
CU20120095A7 (es) Antagonistas de pcsk9
EA201500172A1 (ru) Модифицированные полипептиды фактора х и их применение
EA201171494A1 (ru) Миметики белка smac
EA200870185A1 (ru) Комбинации ингибиторов ang2 и vegf
WO2006097535A3 (en) Peptide agonists of the glucagon family with secretin like activity
NO20091413L (no) WNT-antagonister og deres anvendelse i diagnostiseringen og behandlingen av WNT-medierte forstyrrelser
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
AR113422A2 (es) Agentes tensioactivos reconstituidos que tienen propiedades mejoradas
TR201900694T4 (tr) 158p1d7 proteinlerine bağlanan antikor ilaç konjugatları (adc).
ATE542139T1 (de) Purinerge (p2x)-rezeptoren in extrazellulärer körperflüssigkeit
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
CO2022005889A2 (es) Derivados terapéuticos de interleucina-22
MX337358B (es) Conjugados de disorazoles y sus derivados con moleculas de union con celulas, nuevos derivados de disorazol, procesos de fabricacion y usos de los mismos.
CY1112121T1 (el) ΠΑΡΑΓΩΓΑ ΤΩΝ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-[1,2-α]-ΠΥΡΑΖΙΝ-6-ΚΑΡΒΟΞΑΜΙΔΙΩΝ ΚΑΙ ΤΩΝ 2,3,4,5-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-(1,2-α)-ΔΙΑΖΕΠΙΝ-7-ΚΑΡΒΟΞΑΜΙΔΙΩΝ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ
CY1114811T1 (el) Νεα κλασματα πρωτεϊνων γαλακτος και η χρηση τους για την προληψη ή τη θεραπεια των χρονιων φλεγμονωδων νοσων
DK1869185T3 (da) Konjugat med P21-protein til kræftbehandling
BRPI0812026A2 (pt) mutantes de vegf-d e seu uso

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.